OTC:CASIF | Cash Flow Statement | CASI Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$48.06M$1.2M-$20.75M$16,000.00$951,000.00$11.25M
2024-12-31-$39.26M$1.3M-$29.22M$223,000.00$11.24M$15.43M
2023-12-31-$26.96M$2.5M-$19.97M$204,000.00-$9.67M$278,000.00-$907,000.00
2022-12-31-$41.01M$1.2M-$21.09M$5.61M$31.16M$3.27M-$3.27M
2021-12-31-$36.65M$500,000.00-$26.84M$8.95M-$20.69M$29.64M
2020-12-31-$48.29M$600,000.00-$25.89M$1.5M-$20.72M$47.15M